Arcutis Biotherapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Arcutis Biotherapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2019 to Q2 2024.
  • Arcutis Biotherapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 116M shares, a 89% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 116M +54.8M +89% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 116M +54.1M +88.2% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 96.8M +35.7M +58.5% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 61.9M +935K +1.53% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 61.6M +10.1M +19.6% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 61.4M +9.96M +19.4% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 61.1M +10.7M +21.3% Dec 31, 2022 10-K 2024-02-27
Q3 2022 60.9M +10.7M +21.2% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 51.5M +1.32M +2.62% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 51.4M +1.26M +2.52% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 50.3M +6.67M +15.3% Dec 31, 2021 10-K 2023-02-28
Q3 2021 50.3M +12M +31.5% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 50.2M +12M +31.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 50.1M +12M +31.4% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 43.7M +40.8M +1417% Dec 31, 2020 10-K 2022-02-22
Q3 2020 38.2M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 38.2M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 38.2M Mar 31, 2020 10-Q 2020-05-12
Q4 2019 2.88M Dec 31, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.